Impact of Female Sex on Outcomes Following Catheter Ablation in Persistent AF
L. Segan(Baker Heart and Diabetes Institute), P. Kistler, H. Sugumar(Baker Heart and Diabetes Institute), Jeremy William(Baker Heart and Diabetes Institute), Rachel Crowley(St. Vincent's University Hospital), Liang‐Han Ling, P. Sanders(Royal Adelaide Hospital), Matthew Ginks(St Thomas' Hospital), A. Voskoboinik(Baker Heart and Diabetes Institute), S. Prabhu(Baker Heart and Diabetes Institute), J. Morton(The Royal Melbourne Hospital), Laurence D. Sterns(Victoria Hospital), D. Chieng(Baker Heart and Diabetes Institute), J. Hawson(The Royal Melbourne Hospital), J. Kálmán(The Royal Melbourne Hospital), Geraldine Lee(University College Cork)
Cited by 0
Related Papers
Radiofrequency Ablation vs Antiarrhythmic Drugs as First-Line Treatment of Paroxysmal Atrial Fibrillation (RAAFT-2)
|JAMA|2014|662
Catheter Ablation of Atrial Fibrillation in Patients With Left Ventricular Systolic Dysfunction
|Circulation Arrhythmia and Electrophysiology|2014|173
Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period
|Calcified Tissue International|2019|160
Length-dependent tension in the failing heart and the efficacy of cardiac resynchronization therapy
|Cardiovascular Research|2010|155